Scaling Up Innovation in Cardiovascular Health

VR can act as consortium partner providing real-world insights on scaling up innovations. VR can contribute to roadmapping and best practices by sharing lessons learned from taking nutraceutical prototypes to market. They could co-lead tasks on validating innovations (e.g. running a pilot study of a nutraceutical in multiple clinics) and contribute to developing guidelines for integrating such innovations into healthcare. While a CSA is largely coordination, VR’s involvement would ensure industry perspectives (manufacturing, regulatory, commercialization) are well represented in strategies to implement CV innovations across Europe. VR could also support dissemination through its network in the nutraceutical and functional food industry.